Allmed Solutions Ltd (ALMD) - Total Assets
Based on the latest financial reports, Allmed Solutions Ltd (ALMD) holds total assets worth ILA31.54 Million ILA (≈ $84.57K USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Allmed Solutions Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Allmed Solutions Ltd - Total Assets Trend (2008–2025)
This chart illustrates how Allmed Solutions Ltd's total assets have evolved over time, based on quarterly financial data. See Allmed Solutions Ltd shareholders equity for net asset value and shareholders' equity analysis.
Allmed Solutions Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Allmed Solutions Ltd's total assets of ILA31.54 Million consist of 96.4% current assets and 3.7% non-current assets.
| Asset Category | Amount (ILA) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 13.1% |
| Accounts Receivable | ILA0.00 | 0.0% |
| Inventory | ILA0.00 | 0.0% |
| Property, Plant & Equipment | ILA0.00 | 0.0% |
| Intangible Assets | ILA0.00 | 0.0% |
| Goodwill | ILA0.00 | 0.0% |
Asset Composition Trend (2008–2025)
This chart illustrates how Allmed Solutions Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Allmed Solutions Ltd (ALMD) total market value.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Allmed Solutions Ltd's current assets represent 96.4% of total assets in 2025, an increase from 90.5% in 2008.
- Cash Position: Cash and equivalents constituted 13.1% of total assets in 2025, down from 60.8% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2008.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
Allmed Solutions Ltd Competitors by Total Assets
Key competitors of Allmed Solutions Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Xiangyu Medical Co. Ltd. A
SHG:688626
|
China | CN¥3.27 Billion |
|
HOB Biotech Group Corp Ltd
SHG:688656
|
China | CN¥912.83 Million |
|
Shanghai Sanyou Medical Co Ltd
SHG:688085
|
China | CN¥2.34 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.02 Billion |
|
Polynovo Ltd
AU:PNV
|
Australia | AU$123.37 Million |
|
Imricor Medical Systems Inc
AU:IMR
|
Australia | AU$45.79 Million |
|
Profound Medical Corp
TO:PRN
|
Canada | CA$102.51 Million |
|
Affluent Medical SAS
PA:AFME
|
France | €59.84 Million |
Allmed Solutions Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 10.31 | 17.24 | 6.95 |
| Quick Ratio | 10.31 | 17.24 | 6.68 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ILA27.44 Million | ILA41.26 Million | ILA35.75 Million |
Allmed Solutions Ltd - Advanced Valuation Insights
This section examines the relationship between Allmed Solutions Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.28 |
| Latest Market Cap to Assets Ratio | 0.26 |
| Asset Growth Rate (YoY) | -29.6% |
| Total Assets | ILA31.54 Million |
| Market Capitalization | $8.17 Million USD |
Valuation Analysis
Below Book Valuation: The market values Allmed Solutions Ltd's assets below their book value (0.26x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Allmed Solutions Ltd's assets decreased by 29.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Allmed Solutions Ltd (2008–2025)
The table below shows the annual total assets of Allmed Solutions Ltd from 2008 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ILA31.54 Million ≈ $84.57K |
-29.58% |
| 2024-12-31 | ILA44.79 Million ≈ $120.09K |
-24.29% |
| 2023-12-31 | ILA59.17 Million ≈ $158.63K |
+2.41% |
| 2022-12-31 | ILA57.77 Million ≈ $154.89K |
+5.44% |
| 2021-12-31 | ILA54.80 Million ≈ $146.90K |
-2.78% |
| 2020-12-31 | ILA56.36 Million ≈ $151.10K |
-16.14% |
| 2019-12-31 | ILA67.20 Million ≈ $180.17K |
+55.97% |
| 2018-12-31 | ILA43.09 Million ≈ $115.52K |
-16.90% |
| 2017-12-31 | ILA51.85 Million ≈ $139.02K |
-0.70% |
| 2016-12-31 | ILA52.22 Million ≈ $140.00K |
-8.31% |
| 2015-12-31 | ILA56.95 Million ≈ $152.69K |
+27.00% |
| 2014-12-31 | ILA44.85 Million ≈ $120.23K |
+2.85% |
| 2013-12-31 | ILA43.60 Million ≈ $116.90K |
-45.85% |
| 2012-12-31 | ILA80.52 Million ≈ $215.88K |
+1.22% |
| 2011-12-31 | ILA79.55 Million ≈ $213.28K |
+122.37% |
| 2010-12-31 | ILA35.78 Million ≈ $95.91K |
+211.66% |
| 2009-12-31 | ILA11.48 Million ≈ $30.77K |
-25.86% |
| 2008-12-31 | ILA15.48 Million ≈ $41.51K |
-- |
About Allmed Solutions Ltd
Allmed Solutions Ltd develops, manufactures, and markets minimally invasive products in various medical disciplines in Israel and internationally. The company offers drugs, biological products, and medical devices; and ProCatid system, a distal embolic protection system comprised of an independent filter unit that can be delivered, locked, and deployed on any commercially marketed guide wires. It… Read more